The News Review:
- New family medicine residents come to work; some graduates are …
- Irish patients and Irish medicine involved in largest worldwide …
- Common drugs offer aging disease hope
- Poster boy
- Resolvyx Scientific Advisors Publish First In-Vivo Data Showing …
- Researchers Identify Tumor Suppressor That Manages Cellular …
New family medicine residents come to work; some graduates are …
The Casper Star Tribune, WY
And he did it all alone. "I realized I was the only doctor in town," Ross said of that night he worked in the small, rural hospital in Lusk. Nothing too traumatic happened, but the experience prepared him for a career as a rural family medicine doctor. One shift in a Lander clinic, a woman came in with respiratory failure. Once again, Ross looked around and saw he was the only physician in the building. He quickly stabilized the woman and escorted her to the hospital.
Irish patients and Irish medicine involved in largest worldwide …
Biotechnology Ireland, Ireland
The ADVANCE trial is the largest of its kind ever conducted with 11,140 taking part in the trial throughout 20 countries over five years. Ireland had 442 patients on the trial under the guidance of five Irish centres. This arm of the trial used the oral anti-diabetic Medicine (gliclazide MR 30 mg) which is produced by the French pharmaceutical company Servier in its plant in Arklow Co Wicklow. The ADVANCE results go beyond existing evidence as they have now shown that reducing haemoglobin A1c level (a marker of blood glucose control) to 6. 5% is a safe and effective way to reduce serious complications, particularly the risk of kidney disease, one of the most serious and disabling consequences of diabetes, leading to death of one in five people with diabetes worldwide. Dr Richard Firth, Consultant Endocrinologist, Mater Misericordiae Hospital, Dublin, one of the Irish investigators involved in the ADVANCE trial commented ‘The ADVANCE glucose results are good news for Irish patients with diabetes. This was a landmark trial considering that there are very few large controlled studies of this nature they really provide clear evidence that more intensive glucose lowering protects the kidney.
Common drugs offer aging disease hope
New Scientist (subscription), UK
The damaged prelamin A binds to molecular fragments in the body called farnesyls, which in turn bind to the nuclear membrane, causing the build-up of protein that underlies the disease. Statins, which are used to reduce cholesterol, and bisphosphonates, which curb osteoporosis, are known to reduce farnesyl levels, so Carlos L
Leave a Comment